Interpretation of Preoperative Management of Medications for Psychiatric Diseases:Society for Perioperative Assessment and Quality Improvement Consensus Statement
10.3870/j.issn.1004-0781.2024.07.002
- VernacularTitle:《精神疾病治疗药物的术前管理:围手术期评估和质量改善协会共识声明》解读
- Author:
Han XIE
1
;
Xudong MA
;
Weihong GE
;
Haixia ZHANG
;
Mengdi SHENG
Author Information
1. 南京大学医学院附属鼓楼医院药学部,南京 210008
- Keywords:
Medication for mental disorders;
Perioperative drug management;
Interpretation of guidelines
- From:
Herald of Medicine
2024;43(7):1038-1045
- CountryChina
- Language:Chinese
-
Abstract:
The lack of preoperative guidelines for the management of drugs for psychiatric disorders will affect the quality of surgical management of psychiatric patients and increase the probability of perioperative complications.To standardize the preoperative management of medications for the treatment of mental disorders,the Perioperative Assessment and Quality Improvement Society issued《Preoperative Management of Medications for Psychiatric Diseases:Society for Perioperative Assessment and Quality Improvement Consensus Statement》in February 2022 to provide clinicians with recommendations for the preoperative management of psychotropic medications.This article interpreted the consensus,summarized the perioperative interactions,special precautions,and auxiliary examination precautions,and provided corresponding preoperative suggestions on antidepressants,mood stabilizers,anxiety,antipsychotics,and attention deficit hyperactivity disorder drugs,to provide a reference for the standardized management of perioperative drugs.